Reports
Latest reports in Health.
Analysis of UPS's expansion of 27 cold transfer facilities and its potential impact on competition in the pharmaceutical cold-chain logistics market, with projections of market growth and rival responses.
UPS invested $48 million in 27 temperature-controlled cross-dock facilities that maintain 2-8°C, 15-25°C, and frozen conditions, are IATA CEIV Pharma certified, and feature a 24/7/365 control tower for proactive monitoring and rapid intervention.
This report examines the primary causes of pharmaceutical cold chain failures, including human errors, equipment malfunctions, and temperature excursions, and details the consequences such as drug degradation, massive financial losses, patient safety risks, regulatory non-compliance, and reputational damage.
Developing vaccines against multiple respiratory virus families is hindered by viruses' ability to manipulate host immune defenses. Rapid viral evolution further requires constant reformulation, complicating cross-protective design.
Broad-spectrum preventatives like far-UVC light and triethylene glycol, combined with air cleaning technologies such as ventilation and filtration, form a layered defense that reduces airborne viral concentrations and lowers pandemic risk.
This report synthesizes evidence on long-term cardiovascular, neurological, and respiratory risks following influenza and RSV infections, and compares the long-term morbidity of both viruses. It also outlines pathways through which acute infections can trigger chronic post-viral illnesses.
